{
    "Trade/Device Name(s)": [
        "Cholesterol2"
    ],
    "Submitter Information": "Abbott Ireland Diagnostics Division",
    "510(k) Number": "K203597",
    "Predicate Device Reference 510(k) Number(s)": [
        "K981652"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "CHH"
    ],
    "Summary Letter Date": "March 25, 2022",
    "Summary Letter Received Date": "March 28, 2022",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1175"
    ],
    "Regulation Name(s)": [
        "Cholesterol (total) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cholesterol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Serum separator tube",
        "Lithium heparin tube",
        "Lithium heparin separator tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT c System",
        "ARCHITECT c8000 System"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay"
    ],
    "Methodologies": [
        "Enzymatic"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott Cholesterol2 enzymatic assay for quantitation of cholesterol in human serum or plasma on ARCHITECT c Systems",
    "Indications for Use Summary": "Used for quantitation of cholesterol in human serum or plasma as an aid in the diagnosis and treatment of disorders involving excess cholesterol and lipid/lipoprotein metabolism disorders",
    "fda_folder": "Clinical Chemistry"
}